125 related articles for article (PubMed ID: 9551904)
1. Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis.
Frey BM; Rafii S; Teterson M; Eaton D; Crystal RG; Moore MA
J Immunol; 1998 Jan; 160(2):691-9. PubMed ID: 9551904
[TBL] [Abstract][Full Text] [Related]
2. [Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis].
Frey BM; Rafii S; Crystal RG; Moore MA
Schweiz Med Wochenschr; 1998 Oct; 128(42):1587-92. PubMed ID: 9824887
[TBL] [Abstract][Full Text] [Related]
3. Major effects of TPO delivered by a single injection of a recombinant adenovirus on prevention of septicemia and anemia associated with myelosuppression in mice: risk of sustained expression inducing myelofibrosis due to immunosuppression.
Abina MA; Tulliez M; Lacout C; Debili N; Villeval JL; Pflumio F; Wendling F; Vainchenker W; Haddada H
Gene Ther; 1998 Apr; 5(4):497-506. PubMed ID: 9614574
[TBL] [Abstract][Full Text] [Related]
4. Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin.
Wagner-Ballon O; Chagraoui H; Prina E; Tulliez M; Milon G; Raslova H; Villeval JL; Vainchenker W; Giraudier S
J Immunol; 2006 Jun; 176(11):6425-33. PubMed ID: 16709799
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of blood platelet levels by intratracheal administration of an adenovirus vector encoding human thrombopoietin cDNA.
Cannizzo SJ; Frey BM; Raffi S; Moore MA; Eaton D; Suzuki M; Singh R; Mack CA; Crystal RG
Nat Biotechnol; 1997 Jun; 15(6):570-3. PubMed ID: 9181581
[TBL] [Abstract][Full Text] [Related]
6. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis.
Nagata Y; Shozaki Y; Nagahisa H; Nagasawa T; Abe T; Todokoro K
Thromb Haemost; 1997 May; 77(5):808-14. PubMed ID: 9184382
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin (TPO) knockout phenotype induced by cross-reactive antibodies against TPO following injection of mice with recombinant adenovirus encoding human TPO.
Abina MA; Tulliez M; Duffour MT; Debili N; Lacout C; Villeval JL; Wendling F; Vainchenker W; Haddada H
J Immunol; 1998 May; 160(9):4481-9. PubMed ID: 9574554
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis.
Kakumitsu H; Kamezaki K; Shimoda K; Karube K; Haro T; Numata A; Shide K; Matsuda T; Oshima K; Harada M
Leuk Res; 2005 Jul; 29(7):761-9. PubMed ID: 15927672
[TBL] [Abstract][Full Text] [Related]
9. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
10. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.
Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T; Nakahata T
Eur J Haematol; 2009 Apr; 82(4):247-54. PubMed ID: 19183407
[TBL] [Abstract][Full Text] [Related]
11. In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression.
Ohwada A; Rafii S; Moore MA; Crystal RG
Blood; 1996 Aug; 88(3):778-84. PubMed ID: 8704230
[TBL] [Abstract][Full Text] [Related]
12. Efficient assay for evaluating human thrombopoiesis using NOD/SCID mice transplanted with cord blood CD34+ cells.
Suzuki K; Hiramatsu H; Fukushima-Shintani M; Heike T; Nakahata T
Eur J Haematol; 2007 Feb; 78(2):123-30. PubMed ID: 17087740
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model.
van Hensbergen Y; Schipper LF; Brand A; Slot MC; Welling M; Nauta AJ; Fibbe WE
Exp Hematol; 2006 Jul; 34(7):943-50. PubMed ID: 16797422
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral-mediated TGF-beta1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis development.
Gastinne T; Vigant F; Lavenu-Bombled C; Wagner-Ballon O; Tulliez M; Chagraoui H; Villeval JL; Lacout C; Perricaudet M; Vainchenker W; Benihoud K; Giraudier S
Exp Hematol; 2007 Jan; 35(1):64-74. PubMed ID: 17198875
[TBL] [Abstract][Full Text] [Related]
15. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.
Grossmann A; Lenox J; Ren HP; Humes JM; Forstrom JW; Kaushansky K; Sprugel KH
Exp Hematol; 1996 Aug; 24(10):1238-46. PubMed ID: 8765500
[TBL] [Abstract][Full Text] [Related]
17. T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation.
Verlinden SF; Mulder AH; de Leeuw JP; van Bekkum DW
Stem Cells; 1998; 16 Suppl 1():205-17. PubMed ID: 11012164
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietin gene transfer-mediated enhancement of angiogenic responses to acute ischemia.
Amano H; Hackett NR; Rafii S; Crystal RG
Circ Res; 2005 Aug; 97(4):337-45. PubMed ID: 16051888
[TBL] [Abstract][Full Text] [Related]
19. Support of hMSCs transduced with TPO/FL genes to expansion of umbilical cord CD34+ cells in indirect co-culture.
Xie C; Jia B; Xiang Y; Wang L; Wang G; Huang G; McNiece IK; Wang J
Cell Tissue Res; 2006 Oct; 326(1):101-10. PubMed ID: 16685532
[TBL] [Abstract][Full Text] [Related]
20. MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions.
Schilz AJ; Schiedlmeier B; Kühlcke K; Fruehauf S; Lindemann C; Zeller WJ; Grez M; Fauser AA; Baum C; Eckert HG
Mol Ther; 2000 Dec; 2(6):609-18. PubMed ID: 11124062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
